[go: up one dir, main page]

NO970340L - Organiske forbindelser - Google Patents

Organiske forbindelser

Info

Publication number
NO970340L
NO970340L NO970340A NO970340A NO970340L NO 970340 L NO970340 L NO 970340L NO 970340 A NO970340 A NO 970340A NO 970340 A NO970340 A NO 970340A NO 970340 L NO970340 L NO 970340L
Authority
NO
Norway
Prior art keywords
organic compounds
cyclopepolides
lcu
leu
diseases
Prior art date
Application number
NO970340A
Other languages
English (en)
Other versions
NO970340D0 (no
Inventor
Michael Morris Dreyfuss
Carolyn Ann Foster
Hans-Ulrich Naegeli
Berndt Oberhauser
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415168A external-priority patent/GB9415168D0/en
Priority claimed from GBGB9504332.9A external-priority patent/GB9504332D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NO970340L publication Critical patent/NO970340L/no
Publication of NO970340D0 publication Critical patent/NO970340D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)

Abstract

Cyklopepcolider med formel I I¿ A-B - R,Leu - Lcu - C - X - Y n I hvori A, B, RjLeu, Leu, C, X og Y er som definert, og som er inhibitorer av adhesjonsmolekylekspresjon og som således kan anvendes for å behandle inflammatoriske og andre sykdommer som involverer ®kte nivåer av adhesjonsmolekylekspresjon.
NO970340A 1994-07-27 1997-01-27 Organiske forbindelser NO970340D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9415168A GB9415168D0 (en) 1994-07-27 1994-07-27 Organic compounds
GBGB9504332.9A GB9504332D0 (en) 1995-03-03 1995-03-03 Organic compounds
PCT/EP1995/002966 WO1996003430A1 (en) 1994-07-27 1995-07-26 Organic compounds

Publications (2)

Publication Number Publication Date
NO970340L true NO970340L (no) 1997-01-27
NO970340D0 NO970340D0 (no) 1997-01-27

Family

ID=26305345

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970340A NO970340D0 (no) 1994-07-27 1997-01-27 Organiske forbindelser

Country Status (25)

Country Link
US (1) US6013627A (no)
EP (1) EP0775158B1 (no)
JP (1) JP3425763B2 (no)
KR (1) KR100378974B1 (no)
CN (1) CN1116304C (no)
AT (1) ATE187461T1 (no)
AU (1) AU702332B2 (no)
BR (1) BR9508342A (no)
CA (1) CA2192786C (no)
CY (1) CY2225B1 (no)
CZ (1) CZ289311B6 (no)
DE (1) DE69513837T2 (no)
DK (1) DK0775158T3 (no)
ES (1) ES2142490T3 (no)
FI (1) FI970279L (no)
GR (1) GR3032698T3 (no)
HU (1) HUT77388A (no)
MX (1) MX9606494A (no)
NO (1) NO970340D0 (no)
NZ (1) NZ291168A (no)
PL (1) PL181990B1 (no)
PT (1) PT775158E (no)
RU (1) RU2155772C2 (no)
SK (1) SK11797A3 (no)
WO (1) WO1996003430A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
US6011136A (en) * 1995-11-21 2000-01-04 Novartis Ag Cyclopeptolides
WO1999014082A1 (en) 1996-09-18 1999-03-25 Minnesota Mining And Manufacturing Company Adhesively-bonded inflatable restraint and method of making
US6365619B1 (en) 1999-07-22 2002-04-02 Novartis Ag Treatment of arteriosclerosis
CA2383451A1 (en) * 1999-08-24 2001-03-01 Ariad Gene Therapeutics, Inc. 28-epirapalogs
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
WO2002034283A2 (en) * 2000-10-27 2002-05-02 Novartis Ag Vegh inhibitors and their use
GB0028367D0 (en) * 2000-11-21 2001-01-03 Celltech Chiroscience Ltd Chemical compounds
GB0101598D0 (en) * 2001-01-22 2001-03-07 Novartis Ag Organic compounds
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
WO2009089549A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
JP6525971B2 (ja) 2013-06-11 2019-06-05 タカラ バイオ ユーエスエー， インコーポレイテッド タンパク質富化微細小胞、タンパク質富化微細小胞の作製方法及び使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425428A (en) * 1982-04-08 1984-01-10 Monsanto Company Novel peptide and peptolide substrates for mammalian collagenase
US4443367A (en) * 1982-04-08 1984-04-17 Monsanto Company Peptide and peptolide substrates for mammalian collagenase
ES2056954T3 (es) * 1987-06-19 1994-10-16 Sandoz Ag Peptolidos ciclicos.
DE3832059A1 (de) * 1988-09-21 1990-03-29 Howaldtswerke Deutsche Werft Tauchtiefengesteuerte ausblasventil-einrichtung
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
ATE187461T1 (de) 1999-12-15
DE69513837D1 (de) 2000-01-13
PL181990B1 (pl) 2001-10-31
RU2155772C2 (ru) 2000-09-10
DE69513837T2 (de) 2000-05-18
FI970279A7 (fi) 1997-01-23
NZ291168A (en) 1998-06-26
FI970279A0 (fi) 1997-01-23
PL317349A1 (en) 1997-04-01
MX9606494A (es) 1997-03-29
CY2225B1 (en) 2003-04-18
BR9508342A (pt) 1997-10-21
US6013627A (en) 2000-01-11
AU3222195A (en) 1996-02-22
SK11797A3 (en) 1997-07-09
WO1996003430A1 (en) 1996-02-08
CA2192786A1 (en) 1996-02-08
DK0775158T3 (da) 2000-05-22
EP0775158A1 (en) 1997-05-28
HUT77388A (hu) 1998-04-28
NO970340D0 (no) 1997-01-27
GR3032698T3 (en) 2000-06-30
HK1014011A1 (en) 1999-09-17
EP0775158B1 (en) 1999-12-08
PT775158E (pt) 2000-05-31
AU702332B2 (en) 1999-02-18
CA2192786C (en) 2009-06-16
CZ289311B6 (cs) 2001-12-12
JP3425763B2 (ja) 2003-07-14
FI970279L (fi) 1997-01-23
KR100378974B1 (ko) 2003-10-08
CN1116304C (zh) 2003-07-30
JPH10504540A (ja) 1998-05-06
CZ22197A3 (en) 1997-05-14
CN1154705A (zh) 1997-07-16
ES2142490T3 (es) 2000-04-16

Similar Documents

Publication Publication Date Title
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
NO20062292L (no) Fremgangsmate for behandling av transplantasjonsavstoting
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
NO931695L (no) Nye 4-arylpiperaciner og 4-arylpiperidiner
NO20031192D0 (no) Isoksazoler og deres anvendelse som inhibitorer av ERK
NO20051600L (no) 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
NO20021358D0 (no) Alkylendiamin-substituerte heterocykler
NO970340L (no) Organiske forbindelser
NO983688L (no) Serin-protease-inhibitorer
ATE231837T1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
BR9811099A (pt) Inibidores de urocinase
PT734259E (pt) Utilizacao de derivados de piperidina para o tratamento da esquizofrenia
WO2001081332A3 (en) 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
DK1000034T3 (da) Substituerede 6-alkylphenanthridiner
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
NO911459D0 (no) Anvendelse av metallion-komplekser som belegginhibitorer.
SE0004101D0 (sv) New use
NO20023111D0 (no) Utvortes preparat for behandling av pruritus
NO20022000L (no) 6-metoksy-2-naftyleddiksyre-prodrogesammensetninger til behandling av inflammasjon
DE69719218D1 (de) Verwendung von pvp oder povidone zum reduzieren von darmschwellungen
MY115877A (en) Cyclopeptolides
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
EP0811620A4 (en) PHENYLAMIDINOTHIOPHENE DERIVATIVES AND ANTIPHLOGISTIC AGENT CONTAINING THEM
NO964291L (no) Fremgangsmåte for behandling av allergisk rinitt